#USA #Miami #Life Sciences #Vanda Pharmaceuticals

Vanda Pharmaceuticals to Present at Citizens Life Sciences Conference 2026

Vanda Pharmaceuticals Inc. has officially announced its participation in the 2026 Citizens Life Sciences Conference, scheduled to take place in Miami on March 11, 2026. As a significant player in the biopharmaceutical industry, Vanda aims to highlight its dedication to developing groundbreaking therapies that address unmet medical needs.

Event Details

The conference is expected to draw attention from stakeholders across the life sciences spectrum. Vanda's corporate presentation is set to begin at 2:15 PM Eastern Time, which attendees can access via Vanda's corporate website. Investors planning to join should navigate to the Investors section on Vanda Pharmaceuticals' website and find the link under 'Recent Events'. It is recommended that they log in at least 15 minutes prior to the presentation to ensure a smooth experience.

This initiative reflects Vanda's ongoing commitment to transparency and investor relations. For those unable to attend the live presentation, an archived version will be available for approximately 30 days after the event, allowing broader access to those interested in Vanda's recent developments and future direction.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals is recognized globally for its innovative approaches to biopharmaceutical development. The company's primary focus is on bringing forth therapies that address significant gaps in medical care, thereby improving the quality of life for patients. With products that span various therapeutic areas, Vanda is at the forefront of transforming healthcare with its commitment to research and development.

For detailed information about Vanda Pharmaceuticals, including their latest advancements and company profile, interested parties can visit their official website or follow them on social media platforms, including X (formerly Twitter) at @vandapharma. Such outreach ensures that investors and the public remain informed about ongoing efforts to advance medicine.

In summary, attendance at the Citizens Life Sciences Conference is a powerful opportunity for Vanda to reach stakeholders eager to understand the latest in biopharmaceuticals. The company's proactive stance in participating reflects its commitment not just to its shareholders but also to the numerous patients who benefit from its innovative solutions.

To connect or for additional inquiries, Kevin Moran, Senior Vice President, Chief Financial Officer and Treasurer of Vanda Pharmaceuticals, can be reached at (202) 734-3400 or via email at [email protected]. This level of accessibility underscores Vanda's dedication to open communication and the sharing of essential information vital to investors and stakeholders alike.

With an evolving landscape in pharmaceuticals and an ever-increasing focus on patient-centered care, Vanda Pharmaceuticals is poised to make waves in Miami during this year's conference. Investors, health professionals, and other interested individuals are encouraged to participate and learn more about the pivotal work being carried out in the realm of healthcare.